I have been part of MSD Carlow from the start. When the site was opened 10 years ago we were in start-up mode – the manufacturing building and labs were being built and fitted out, our teams were ...
Pharmaceutical Technology on MSN
MSD pays up to nearly $600m for Evaxion’s mystery vaccine candidate
Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback